These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 19804979)
1. Hybrid pharmacophore design and synthesis of isatin-benzothiazole analogs for their anti-breast cancer activity. Solomon VR; Hu C; Lee H Bioorg Med Chem; 2009 Nov; 17(21):7585-92. PubMed ID: 19804979 [TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of anti-breast cancer agents from 4-piperazinylquinoline: a hybrid pharmacophore approach. Solomon VR; Hu C; Lee H Bioorg Med Chem; 2010 Feb; 18(4):1563-72. PubMed ID: 20106668 [TBL] [Abstract][Full Text] [Related]
3. Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo. Shi DF; Bradshaw TD; Wrigley S; McCall CJ; Lelieveld P; Fichtner I; Stevens MF J Med Chem; 1996 Aug; 39(17):3375-84. PubMed ID: 8765521 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and anticancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety. Havrylyuk D; Mosula L; Zimenkovsky B; Vasylenko O; Gzella A; Lesyk R Eur J Med Chem; 2010 Nov; 45(11):5012-21. PubMed ID: 20810193 [TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of chloroquine analogs with anti-breast cancer property. Solomon VR; Hu C; Lee H Eur J Med Chem; 2010 Sep; 45(9):3916-23. PubMed ID: 20561720 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel isatin-thiazoline and isatin-benzimidazole conjugates as anti-breast cancer agents. Taher AT; Khalil NA; Ahmed EM Arch Pharm Res; 2011 Oct; 34(10):1615-21. PubMed ID: 22076761 [TBL] [Abstract][Full Text] [Related]
7. Antitumor benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines. Mortimer CG; Wells G; Crochard JP; Stone EL; Bradshaw TD; Stevens MF; Westwell AD J Med Chem; 2006 Jan; 49(1):179-85. PubMed ID: 16392802 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles. Kumar D; Maruthi Kumar N; Chang KH; Shah K Eur J Med Chem; 2010 Oct; 45(10):4664-8. PubMed ID: 20692741 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of 3-substituted-2-oxoindole analogues and their evaluation as kinase inhibitors, anticancer and antiangiogenic agents. Abadi AH; Abou-Seri SM; Abdel-Rahman DE; Klein C; Lozach O; Meijer L Eur J Med Chem; 2006 Mar; 41(3):296-305. PubMed ID: 16494969 [TBL] [Abstract][Full Text] [Related]
11. Cytostatic and cytotoxic action of Z-1, 1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines. ter Haar E; Day BW Anticancer Res; 1996; 16(3A):1107-15. PubMed ID: 8702221 [TBL] [Abstract][Full Text] [Related]
12. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines. Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and anticancer activity of novel 3,4-diarylthiazol-2(3H)-ones (imines). Liu ZY; Wang YM; Li ZR; Jiang JD; Boykin DW Bioorg Med Chem Lett; 2009 Oct; 19(19):5661-4. PubMed ID: 19713108 [TBL] [Abstract][Full Text] [Related]
14. Anti-breast cancer activity of heteroaryl chalcone derivatives. Solomon VR; Lee H Biomed Pharmacother; 2012 Apr; 66(3):213-20. PubMed ID: 22440895 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiproliferative activity of 2-aryl-4-oxo-thiazolidin-3-yl-amides for prostate cancer. Gududuru V; Hurh E; Dalton JT; Miller DD Bioorg Med Chem Lett; 2004 Nov; 14(21):5289-93. PubMed ID: 15454213 [TBL] [Abstract][Full Text] [Related]
16. A radiometric method for evaluation of chemotherapy sensitivity: results of screening a panel of human breast cancer cell lines. Arteaga CL; Forseth BJ; Clark GM; Von Hoff DD Cancer Res; 1987 Dec; 47(23):6248-53. PubMed ID: 3119196 [TBL] [Abstract][Full Text] [Related]
17. Discovery and potency optimization of 2-amino-5-arylmethyl-1,3-thiazole derivatives as potential therapeutic agents for prostate cancer. Krasavin M; Karapetian R; Konstantinov I; Gezentsvey Y; Bukhryakov K; Godovykh E; Soldatkina O; Lavrovsky Y; Sosnov AV; Gakh AA Arch Pharm (Weinheim); 2009 Jul; 342(7):420-7. PubMed ID: 19544302 [TBL] [Abstract][Full Text] [Related]
18. Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents. Berry JM; Bradshaw TD; Fichtner I; Ren R; Schwalbe CH; Wells G; Chew EH; Stevens MF; Westwell AD J Med Chem; 2005 Jan; 48(2):639-44. PubMed ID: 15658878 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiproliferative activity of [1,2,3,5]tetrazino[5,4-a]indoles, a new class of azolo-tetrazinones. Barraja P; Diana P; Lauria A; Montalbano A; Almerico AM; Dattolo G; Cirrincione G Bioorg Med Chem; 2005 Jan; 13(2):295-300. PubMed ID: 15598552 [TBL] [Abstract][Full Text] [Related]
20. A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties. Kupchinsky S; Centioni S; Howard T; Trzupek J; Roller S; Carnahan V; Townes H; Purnell B; Price C; Handl H; Summerville K; Johnson K; Toth J; Hudson S; Kiakos K; Hartley JA; Lee M Bioorg Med Chem; 2004 Dec; 12(23):6221-36. PubMed ID: 15519165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]